Providing an automated, precise and reproducible process of harvesting autologous, non-damaged epidermal tissue, the CelluTome system makes the benefits of epidermal grafting accessible to broader range of doctors and patients.

University of Miami Miller’s School of Medicine Dermatology & Cutaneous Surgery department professor and vice chairman Dr Robert Kirsner said that the CelluTome System allows for a simplified and convenient way to harvest epidermis and provide autologous epidermal micrografts.

"Our experience, to date confirms harvesting with minimal, if any, pain and scarring and, most importantly, the ability to graft epidermis to help heal patients’ wounds," Kirsner added.

The new skin harvesting platform aids doctors in harvesting the epidermal grafts consistently while minimising the donor site complications without damaging the donor site.

The product is designed to harvest epidermis at the DE junction1, which permits the skin harvesting without the requirement of the donor site anesthesia.

KCI president and CEO Joe Woody said that the CelluTome Epidermal Harvesting System addresses an unmet need in acquiring skin grafts and gives a broad range of physicians the ability to manage wounds effectively.

"This means the whole process can take place in an outpatient setting, which truly transforms the way physicians have traditionally used skin grafting," Woody added.